This world-first-treatment could potentially offer hope to lung cancer patients with previously untreatable lung tumors.
Browsing: targeted therapy
FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer
Discover details of the first randomized, multicenter Phase III study to compare the safety and efficacy of mirvetuximab soravtansine vs investigator’s choice of chemotherapy in women with folate receptor-α-positive, platinum-resistant epithelial ovarian, primary peritoneal or fallopian tube cancer.
Cytokine-induced killer cell therapy-associated idiopathic thrombocytopenic purpura: rare but noteworthy
Discover more about idiopathic thrombocytopenic purpura in this case report from Immunotherapy.
Results from two international clinical trials yield promising results for halting the mestatise of melanoma, yield novel treatment options for melanoma and may help stop this form of cancer metastizing.
Listen to this exclusive interview with Dirk Arnold from Klinik für Tumorbiologie (Freiburg, Germany) about current treatment options for rectal cancer, how we can define a strategy for oligometastic rectal cancer and his hopes for the future of this field.
Reprogrammed chondrocytes engineered to produce IL-12 provide novel ex vivo immune-gene therapy for cancer
In this research article from Immunotherapy find out about a somatic cell reprogramming procedure which may provide a novel and effective means to treat malignancies.
A group of researchers have uncovered a link between chemo-resistance in pediatric acute lymphoblastic leukaemia and the protein 5T4; early-testing indicates that targeting the protein could help improve treatment outcomes.
A new first-of-its-kind study will assess Zika virus as a tool to target glioblastomas, one of the most challenging cancers to treat.
A comprehensive review article of the avaliable therapeutic strategies developed against malignant gliomas based on ‘actively targeted’ nanoparticles, it discusses challenges, mechanisms, clinical studies and treatment options
This editorial provides and insight into proton beam therapy as a promising treatment for pediatric cancers, it covers the cost effectiveness, clinical concerns and future prospective of the therapy.